Yin Wu, Clinical Lecturer TCT Lab, UCL Cancer Institute
Rethinking Cancer | UCL Cancer Domain Symposium
Monday 13 May 2019
Early Careers Network Session
Cancer remains one of the major causes of morbidity and premature death worldwide; one in two people in the UK born after 1960 will be diagnosed with some form of cancer during their lifetime. UCL has a proud track record in addressing the societal, technical, and health challenges of cancer and in exploring its underling biology.
This symposium, invited our broad community to assemble for the first time at scale to consider challenges and opportunities in cancer research, prevention and treatment, from biological, clinical, technical, economic and societal perspectives.
894
6/6/2019
Alexandra Lubin, Dept of Haematology, UCL Cancer Institute
Rethinking Cancer | UCL Cancer Domain Symposium
Monday 13 May 2019
Early Careers Network Session
Cancer remains one of the major causes of morbidity and premature death worldwide; one in two people in the UK born after 1960 will be diagnosed with some form of cancer during their lifetime. UCL has a proud track record in addressing the societal, technical, and health challenges of cancer and in exploring its underling biology.
This symposium, invited our broad community to assemble for the first time at scale to consider challenges and opportunities in cancer research, prevention and treatment, from biological, clinical, technical, economic and societal perspectives.
635
6/6/2019
Rethinking Cancer | UCL Cancer Domain Symposium
Monday 13 May 2019
Early Careers Network Session
Cancer remains one of the major causes of morbidity and premature death worldwide; one in two people in the UK born after 1960 will be diagnosed with some form of cancer during their lifetime. UCL has a proud track record in addressing the societal, technical, and health challenges of cancer and in exploring its underling biology.
This symposium, invited our broad community to assemble for the first time at scale to consider challenges and opportunities in cancer research, prevention and treatment, from biological, clinical, technical, economic and societal perspectives.
705
6/5/2019
Professor Sam Janes
Wellcome Trust Senior Fellow in Clinical Science;
Professor of Respiratory Medicine, UCL Respiratory
Head, Respiratory Research Dept, UCL
Rethinking Cancer | UCL Cancer Domain Symposium
Monday 13 May 2019
Cancer detection: the earlier the better?
Cancer remains one of the major causes of morbidity and premature death worldwide; one in two people in the UK born after 1960 will be diagnosed with some form of cancer during their lifetime. UCL has a proud track record in addressing the societal, technical, and health challenges of cancer and in exploring its underling biology.
This symposium, invited our broad community to assemble for the first time at scale to consider challenges and opportunities in cancer research, prevention and treatment, from biological, clinical, technical, economic and societal perspectives.
640
6/4/2019
Dr Nora Pashayan
Clinical Reader in Applied Health Research, Research Dept of Applied Health Research, UCL Institute of Epidemiology and Health Care
Rethinking Cancer | UCL Cancer Domain Symposium
Monday 13 May 2019
Cancer detection: the earlier the better?
Cancer remains one of the major causes of morbidity and premature death worldwide; one in two people in the UK born after 1960 will be diagnosed with some form of cancer during their lifetime. UCL has a proud track record in addressing the societal, technical, and health challenges of cancer and in exploring its underling biology.
This symposium, invited our broad community to assemble for the first time at scale to consider challenges and opportunities in cancer research, prevention and treatment, from biological, clinical, technical, economic and societal perspectives.
697
6/4/2019
Professor Caroline Moore
Head of Urology, UCL
Honorary Consultant Urologist, UCLH Trust
Rethinking Cancer | UCL Cancer Domain Symposium
Monday 13 May 2019
Cancer detection: the earlier the better?
Cancer remains one of the major causes of morbidity and premature death worldwide; one in two people in the UK born after 1960 will be diagnosed with some form of cancer during their lifetime. UCL has a proud track record in addressing the societal, technical, and health challenges of cancer and in exploring its underling biology.
This symposium, invited our broad community to assemble for the first time at scale to consider challenges and opportunities in cancer research, prevention and treatment, from biological, clinical, technical, economic and societal perspectives.
612
6/4/2019
Professor Marcel Levi
Dr Claire Roddie
Professor Gary Royle
Professor Daniel Hochhauser
Professor Mariana Mazzucato
Rethinking Cancer | UCL Cancer Domain Symposium
Monday 13 May 2019
The cancer treatment revolution and how we afford it?
Cancer remains one of the major causes of morbidity and premature death worldwide; one in two people in the UK born after 1960 will be diagnosed with some form of cancer during their lifetime. UCL has a proud track record in addressing the societal, technical, and health challenges of cancer and in exploring its underling biology.
This symposium, invited our broad community to assemble for the first time at scale to consider challenges and opportunities in cancer research, prevention and treatment, from biological, clinical, technical, economic and societal perspectives.
654
6/4/2019
Professor Mariana Mazzucato
Professor in the Economics of Innovation and Public Value;
Founder and Director, UCL Institute for Innovation and Public Purpose
Rethinking Cancer | UCL Cancer Domain Symposium
Monday 13 May 2019
The cancer treatment revolution and how we afford it?
Cancer remains one of the major causes of morbidity and premature death worldwide; one in two people in the UK born after 1960 will be diagnosed with some form of cancer during their lifetime. UCL has a proud track record in addressing the societal, technical, and health challenges of cancer and in exploring its underling biology.
This symposium, invited our broad community to assemble for the first time at scale to consider challenges and opportunities in cancer research, prevention and treatment, from biological, clinical, technical, economic and societal perspectives.
625
6/4/2019